P Evelyna Kambanis, Lilian P Palmer, Grace Jhe, Iman McPherson, Haley Graver, Abigail G Dalton, Chunni Ji, Elisa Asanza, Lauren Shabazian, Ashley Dunford, Lauren Breithaupt, Melissa Freizinger, Kamryn T Eddy, Madhusmita Misra, Nadia Micali, Laura Holsen, Elizabeth A Lawson, Kendra R Becker, Jennifer J Thomas
{"title":"Frequency and Predictors of Shape/Weight Concerns and Objective Binge Eating in Avoidant/Restrictive Food Intake Disorder (ARFID).","authors":"P Evelyna Kambanis, Lilian P Palmer, Grace Jhe, Iman McPherson, Haley Graver, Abigail G Dalton, Chunni Ji, Elisa Asanza, Lauren Shabazian, Ashley Dunford, Lauren Breithaupt, Melissa Freizinger, Kamryn T Eddy, Madhusmita Misra, Nadia Micali, Laura Holsen, Elizabeth A Lawson, Kendra R Becker, Jennifer J Thomas","doi":"10.1002/eat.24398","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>DSM-5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co-occur, and DSM-5-TR now permits comorbid binge-eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical-level shape/weight concerns and past-month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical-level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory.</p><p><strong>Method: </strong>Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination-Questionnaire (EDE-Q).</p><p><strong>Results: </strong>Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical-level shape/weight concerns, and 15% reported past-month OBEs. Higher weight uniquely predicted shape/weight concerns.</p><p><strong>Discussion: </strong>Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID-particularly those at higher weights-may experience clinical-level shape/weight concerns and OBEs.</p>","PeriodicalId":51067,"journal":{"name":"International Journal of Eating Disorders","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Eating Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/eat.24398","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: DSM-5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co-occur, and DSM-5-TR now permits comorbid binge-eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical-level shape/weight concerns and past-month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical-level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory.
Method: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination-Questionnaire (EDE-Q).
Results: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical-level shape/weight concerns, and 15% reported past-month OBEs. Higher weight uniquely predicted shape/weight concerns.
Discussion: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID-particularly those at higher weights-may experience clinical-level shape/weight concerns and OBEs.
期刊介绍:
Articles featured in the journal describe state-of-the-art scientific research on theory, methodology, etiology, clinical practice, and policy related to eating disorders, as well as contributions that facilitate scholarly critique and discussion of science and practice in the field. Theoretical and empirical work on obesity or healthy eating falls within the journal’s scope inasmuch as it facilitates the advancement of efforts to describe and understand, prevent, or treat eating disorders. IJED welcomes submissions from all regions of the world and representing all levels of inquiry (including basic science, clinical trials, implementation research, and dissemination studies), and across a full range of scientific methods, disciplines, and approaches.